JPMorgan cuts Dabur India price target to INR495 from INR500

Published 08/05/2025, 06:56
JPMorgan cuts Dabur India price target to INR495 from INR500

On Thursday, JPMorgan adjusted its outlook on Dabur India (NSE:DABU) Ltd. (DABUR:IN), revising the company’s price target down to INR 495 from INR 500, while keeping a Neutral rating on the stock. The change follows Dabur India’s announcement of its fourth-quarter results, which showed a modest year-over-year revenue increase of 1% but a decline in EBITDA and profit after tax (PAT) by 9% and 8%, respectively.

Dabur India experienced a 3% drop in domestic volume, with notable performance setbacks in several product categories including beverages, over-the-counter (OTC) & Ethicals, health supplements, oral care, and hair care. In response to these challenges, Dabur India has shared its updated strategy aimed at driving double-digit revenue and profit compound annual growth rate (CAGR) from the fiscal year 2025 to 2028. The strategy includes concentrating on seven core brands, exiting non-performing segments such as tea, diapers, and health food drinks (HFD), and pursuing premiumization and contemporization of product formats. Additionally, the company is looking into strategic mergers and acquisitions, making bold moves in the health and wellness sector, improving go-to-market agility, and optimizing costs across the value chain.

JPMorgan’s analysis suggests that successful execution of these strategic imperatives is critical for restoring investor confidence and conviction in Dabur India’s stock. However, the firm noted that these initiatives have been part of Dabur’s operational strategy in the past as well.

For the near term, the outlook for the first quarter of the fiscal year 2026 remains cautious, though JPMorgan anticipates a slight sequential improvement. The firm also highlighted that the impact of recent geopolitical events on Dabur India’s international operations is an area of concern.

Despite a recent dip in share price and a moderation in valuations, JPMorgan prefers a cautious stance on Dabur India due to uncertainties surrounding the company’s growth revival.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.